{"disease":{"id":"active-moderate-to-severe-rheumatoid-arthritis","name":"active moderate to severe rheumatoid arthritis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04876781","title":"Korean Post-marketing Surveillance for Xeljanz XR","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Pfizer","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}